About US
Contact us
-
Roche dropping Herceptin price in India by 30%Roche, whose patents have been under attack in India, is moving forward with plans to manufacture some drugs in the country, indicating it will drop the prices by as much as 50%, even as it faces a ne2013/3/4
-
Roche and Hamilton Introduce New Automated DNA Sample Enrichment Platform for GS Junior Sequencing InstrumentsToday Roche and Hamilton Robotics jointly announced the introduction of a new, integrated platform enabling automated DNA sample enrichment for Roche’s 454 GS Juniorsequencer. The platform builds on2013/3/4
-
Sartorius Stedim Biotech Expands PAT Portfolio by Adding Sensor Technology for Real-Time Biomass MeasurementSartorius Stedim Biotech (SSB), a leading international supplier for the pharmaceutical and biotech industries, has entered into a global sales anddevelopment partnership with Aber Instruments (Aber)2013/3/1
-
Bayer bucks pharma trend with 'remarkable' growth in new drugsBayer's new drugs are bringing home the bacon. The German drugmaker raised its 2015 forecast for 5 key products to €2.5 billion ($3.3 billion)--and confirmed previous promises that those drugs would2013/3/1
-
Hospira issues 3 recalls as it faces crucial FDA inspectionSterile injectables maker Hospira ($HSP) is having to recall lots of 5 different products even as FDA inspectors are in one of its plants conducting what the company hopes will be a final inspection2013/2/28
-
Amgen loses Supreme Court ruling in shareholder suitAmgen just can't escape the spotlight. The biotech company was accused last month of getting special favors from lawmakers. Today the U.S. Supreme Court ruled against it in a securities case that set2013/2/28
-
Bayer wins new use for fast-moving cancer drug StivargaBayer's new cancer drug Stivarga has already added a notch to its belt. Cleared by the FDA last year to treat colorectal cancer, the drug is now approved as a treatment for a rare form of gastric can2013/2/27
-
Definiens Appoints Professor Dr. Ralf Huss as Chief Medical OfficerDefiniens, the global leader of image and data analysis solutions for quantitative digital pathology, today announced the appointment of renowned surgical and anatomical pathologist Dr. Ralf Huss as2013/2/27
-
Ranbaxy back in gear for generic Lipitor productionRanbaxy Laboratories is back in the generic Lipitor saddle again. Three months after stopping production of the cholesterol fighter and recalling almost a half-million bottles, the Indian drugmaker s2013/2/26
-
Pfizer eyes more Chinese partners to speed growthEveryone in pharma wants a piece of China. In spite of recent price cuts, China remains one of the fastest-growing drug markets in the world. The question is, what piece? And how can it be had? Appar2013/2/26